CDC backs Moderna COVID-19 shots after full US approval

By AP News

Share:

NEW YORK (AP) — The Centers for Disease Control and Prevention on Friday continued its endorsement of Moderna's COVID-19 vaccine for adults, now that U.S. regulators have given the shots their full approval.

NEW YORK (AP) — The Centers for Disease Control and Prevention on Friday continued its endorsement of Moderna's COVID-19 vaccine for adults, now that U.S. regulators have given the shots their full approval.

The decision has little practical effect. Tens of millions of Americans have already gotten Moderna shots, following its emergency authorization by the Food and Drug Administration more than a year ago.

Earlier this week, the FDA gave the product full licensure, following the kind of rigorous, time-consuming review given to other vaccines.

While the FDA licenses vaccines, the CDC makes recommendations about how they should be used. So the CDC's Advisory Committee on Immunization Practices took up the matter on Friday.

The panel heard summaries of medical studies that showed the vaccine is working against the coronavirus and there is no evidence of new safety concerns. It voted unanimously to continue to endorse the shots, and the agency's director later signed off on the recommendation.

The Moderna vaccine, now being marketed under the name Spikevax, is licensed as a two-dose series for people 18 and older. Under earlier emergency use authorizations, additional doses can be given as additional doses for people with weakened immune systems or as half-dose boosters.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Share:

Author: AP News

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

Originally published by Associated Press Valuethemarkets.com, Digitonic Ltd (and our owners, directors, officers, managers, employees, affiliates, agents and assigns) are not responsible for the content or accuracy of this article. The information included in this article is based solely on information provided by the company or companies mentioned above.

Sign up for VTM Updates

Form submitted successfully!

VTM Exclusive Reports

Crypto Corner

Learn your NFTs from your BTCs